AKT1 and cancer: PDIA3 has been shown to interact with and regulate the activity of AKT and modulate the downstream signaling of the PI3K/AKT pathway, which is a key regulator of cell growth, survival, and metabolism in other types of cancer [[16], [17], [18]].